Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
Clinical trial NCT01416636 · COMPLETED
Trial details
- NCT number
- NCT01416636
- Sponsor
- SciPharm SàRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2016-11-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.